Insulin resistance: what the markers show

Insulin resistance develops for years before glucose looks wrong — and the markers that reveal it early are hiding in plain sight on a standard panel.

What insulin resistance is

Insulin is the hormone that tells cells to take up glucose. Resistance means the cells respond less to the signal — so the pancreas compensates by producing more insulin to get the same job done.

For a long time, the compensation works. Glucose stays normal because insulin is running high to keep it there. That is the deceptive phase: the standard glucose result looks fine while the system behind it strains. Only when compensation begins failing does glucose drift upward — first into the intermediate range, eventually toward type 2 diabetes.

The markers, in order of appearance

Triglycerides and HDL shift early. Insulin resistance pushes triglycerides up and HDL down, and the ratio between them is one of the better ordinary-panel clues that something metabolic is moving.

Fasting glucose and HbA1c move late, for the reason above — they measure the output of a system that compensates. Normal results here do not rule out resistance; rising-within-range results across years are worth noticing.

Fasting insulin measures the compensation itself, which is why it changes earliest of all. It is not on standard panels and its interpretation is less standardised — but conceptually it is the direct view of the problem.

The company it keeps: low SHBG travels with insulin resistance, liver enzymes rise where fat accumulates in the liver, and blood pressure and waist measurement complete a picture no single blood marker gives.

What moves it

The major drivers are excess body fat — visceral fat especially — inactivity, and genetics, with sleep and some conditions contributing. The encouraging inverse: insulin sensitivity responds well to the unglamorous levers. Muscle is the body's largest glucose disposal site, so training builds capacity directly; weight loss where relevant, and activity in any form, measurably improve it.

What these markers won't tell you

• No single number diagnoses it. Insulin resistance is a pattern across markers, measurements and time — assembling it is a clinician's job.
• Normal glucose isn't all-clear. It is the last marker to move, not the first.
• Fasting insulin isn't a home verdict. Less standardised ranges make it a marker to interpret with a doctor, not against the internet.
• The trend beats the snapshot. Values drifting up within range across years are the early signal worth catching.

The bottom line

Insulin resistance announces itself sideways — in triglycerides, HDL, SHBG and liver enzymes — long before glucose admits anything. Reading a panel with that pattern in mind is how the earliest, most reversible stage gets caught.